C. B. Falkson, E. T. Vella, E. Yu, M. El-mallah, R. Mackenzie et al., Guideline for radiotherapy with curative intent in patients with early-stage medically inoperable non-small-cell lung cancer, Curr Oncol, vol.24, issue.1, pp.44-53, 2017.

J. L. Shah and B. W. Loo, Stereotactic ablative radiotherapy for early-stage lung cancer, Semin Radiat Oncol, vol.27, issue.3, pp.218-246, 2017.

A. Maciejczyk, I. Skrzypczynska, and M. Janiszewska, Lung cancer. Radiotherapy in lung cancer: Actual methods and future trends, Rep Pract Oncol Radiother, vol.19, issue.6, pp.353-60, 2014.

S. Kotb, A. Detappe, F. Lux, F. Appaix, E. L. Barbier et al., Gadoliniumbased nanoparticles and radiation therapy for multiple brain melanoma metastases: proof of concept before phase I trial, Theranostics, vol.6, issue.3, pp.418-445, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01266945

L. Duc, G. Miladi, I. Alric, C. Mowat, P. Brauer-krisch et al., Toward an image-guided microbeam radiation therapy using gadolinium-based nanoparticles, ACS Nano, vol.5, issue.12, pp.9566-74, 2011.

C. Verry, S. Dufort, E. L. Barbier, O. Montigon, M. Peoc'h et al., MRI-guided clinical 6-MV radiosensitization of glioma using a unique gadolinium-based nanoparticles injection, Nanomedicine (Lond), vol.11, issue.18, pp.2405-2422, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01405486

F. Lux, V. L. Tran, E. Thomas, S. Dufort, F. Rossetti et al., R)) from bench to bedside-Transfer of an ultrasmall theranostic gadoliniumbased nanoparticle to clinical medicine, Br J Radiol, p.365, 2018.

L. Maggiorella, G. Barouch, C. Devaux, A. Pottier, E. Deutsch et al., Nanoscale radiotherapy with hafnium oxide nanoparticles, Future Oncol, vol.8, issue.9, pp.1167-81, 2012.

R. I. Berbeco, A. Detappe, P. Tsiamas, D. Parsons, M. Yewondwossen et al., Low Z target switching to increase tumor endothelial cell dose enhancement during gold nanoparticle-aided radiation therapy, Med Phys, vol.43, issue.1, p.436, 2016.

J. F. Hainfeld, H. M. Smilowitz, M. J. O'connor, F. A. Dilmanian, and D. N. Slatkin, Gold nanoparticle imaging and radiotherapy of brain tumors in mice, Nanomedicine (Lond), vol.8, issue.10, pp.1601-1610, 2013.

A. Bianchi, S. Dufort, P. Y. Fortin, F. Lux, G. Raffard et al., In vivo MRI for effective non-invasive detection and follow-up of an orthotopic mouse model of lung cancer, NMR Biomed, vol.27, issue.8, pp.971-980, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01115887

S. Dufort, A. Bianchi, M. Henry, F. Lux, L. Duc et al., Nebulized gadolinium-based nanoparticles: a theranostic approach for lung tumor imaging and radiosensitization, Small, vol.11, issue.2, pp.215-236, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01115895

L. Sancey, F. Lux, S. Kotb, S. Roux, S. Dufort et al., The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy, Br J Radiol, vol.87, 1041.
URL : https://hal.archives-ouvertes.fr/hal-01053790

S. Ishiguro, S. Cai, D. Uppalapati, K. Turner, T. Zhang et al., Intratracheal administration of hyaluronan-cisplatin conjugate nanoparticles significantly attenuates lung cancer growth in mice, Pharm Res, vol.33, issue.10, pp.2517-2546, 2016.

W. H. Roa, S. Azarmi, M. H. Al-hallak, W. H. Finlay, A. M. Magliocco et al., Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model, J Control Release, vol.150, issue.1, pp.49-55, 2011.

A. Karageorgis, S. Dufort, L. Sancey, M. Henry, S. Hirsjarvi et al., An MRI-based classification scheme to predict passive access of 5 to 50-nm large nanoparticles to tumors, Sci Rep, vol.6, p.21417, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01388813

K. L. Aillon, N. El-gendy, C. Dennis, J. P. Norenberg, J. Mcdonald et al., Iodinated NanoClusters as an inhaled computed tomography contrast agent for lung visualization, Mol Pharm, vol.7, issue.4, pp.1274-82, 2010.

A. Bianchi, S. Dufort, F. Lux, A. Courtois, O. Tillement et al., Quantitative biodistribution and pharmacokinetics of multimodal gadoliniumbased nanoparticles for lungs using ultrashort TE MRI, MAGMA, vol.27, issue.4, pp.303-319, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01279126

A. Bianchi, S. Dufort, F. Lux, P. Y. Fortin, N. Tassali et al., Targeting and in vivo imaging of non-small-cell lung cancer using nebulized multimodal contrast agents, Proc Natl Acad Sci, vol.111, issue.25, pp.9247-52, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01115890

C. Verry, L. Sancey, S. Dufort, L. Duc, G. Mendoza et al., Treatment of multiple brain metastases using gadolinium nanoparticles and radiotherapy: NANO-RAD, a phase I study protocol, BMJ Open, vol.9, issue.2, p.23591, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02381987

F. Lux, A. Mignot, P. Mowat, C. Louis, S. Dufort et al., Ultrasmall rigid particles as multimodal probes for medical applications, Angew Chem Int Ed Engl, vol.50, issue.51, pp.12299-303, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00658275

Y. Cremillieux, Y. Montigaud, C. Bal, N. Pinaud, V. Pham et al., Three-dimensional quantitative MRI of aerosolized gadolinium-based nanoparticles and contrast agents in isolated ventilated porcine lungs, Magn Reson Med, vol.83, issue.5, pp.1774-82, 2020.
URL : https://hal.archives-ouvertes.fr/hal-02382227

C. Mas, B. Boda, C. Futy, M. Huang, S. Wisniewski et al., Establishment of a tumour-stroma airway model (OncoCilAir) to accelerate the development of human therapies against lung cancer, Altern Lab Anim, vol.44, issue.5, pp.479-85, 2016.

S. Huang, L. Wiszniewski, S. Constant, and E. Roggen, Potential of in vitro reconstituted 3D human airway epithelia (MucilAir) to assess respiratory sensitizers, Toxicol In Vitro, vol.27, issue.3, pp.1151-1157, 2013.

C. Mercier, Z. He, S. Constant, N. Perek, D. Boudard et al., Pharmacological characterization of the 3D MucilAir ? nasal model, Eur J Pharm Biopharm, vol.139, pp.186-96, 2019.

M. Hoshino, S. Morita, H. Iwashita, Y. Sagiya, T. Nagi et al., Increased expression of the human Ca 2+ -activated Cl-channel 1 (CaCC1) gene in the asthmatic airway, Am J Respir Crit Care Med, vol.165, issue.8, pp.1132-1138, 2002.

E. N. Blatt, X. H. Yan, M. K. Wuerffel, D. L. Hamilos, and S. L. Brody, Forkhead transcription factor HFH-4 expression is temporally related to ciliogenesis, Am J Respir Cell Mol Biol, vol.21, issue.2, pp.168-76, 1999.

R. Jain, J. Pan, J. A. Driscoll, J. W. Wisner, T. Huang et al., Temporal relationship between primary and motile ciliogenesis in airway epithelial cells, Am J Respir Cell Mol Biol, vol.43, issue.6, pp.731-740, 2010.

F. Kuper, C. Grollers-mulderij, M. Maarschalkerweerd, T. Meulendijks, N. M. Reus et al., Toxicity assessment of aggregated/agglomerated cerium oxide nanoparticles in an in vitro 3D airway model: the influence of mucociliary clearance, Toxicol In Vitro, vol.29, issue.2, pp.389-97, 2015.

K. Meldrum, S. B. Robertson, I. Romer, T. Marczylo, L. Dean et al., Cerium dioxide nanoparticles exacerbate house dust mite induced type II airway inflammation, Part Fibre Toxicol, vol.15, issue.1, p.24, 2018.

C. Mas, B. Boda, M. Caulfuty, S. Huang, L. Wiszniewski et al., Antitumour efficacy of the selumetinib and trametinib MEK inhibitors in a combined human airway-tumour-stroma lung cancer model, J Biotechnol, vol.205, pp.111-120, 2015.

S. Chortarea, K. Fytianos, L. Rodriguez-lorenzo, A. Petri-fink, and B. Rothen-rutishauser, Distribution of polymer-coated gold nanoparticles in a 3D lung model and indication of apoptosis after repeated exposure, Nanomedicine (Lond), vol.13, issue.10, pp.1169-85, 2018.

B. Drasler, D. Vanhecke, L. Rodriguez-lorenzo, A. Petri-fink, and B. Rothen-rutishauser, Quantifying nanoparticle cellular uptake: which method is best? Nanomedicine (Lond), vol.12, pp.1095-1104, 2017.

A. M. Milosevic, L. Rodriguez-lorenzo, S. Balog, C. A. Monnier, A. Petri-fink et al., Assessing the stability of fluorescently encoded nanoparticles in lysosomes by using complementary methods, Angew Chem Int Ed Engl, vol.56, issue.43, pp.13382-13388, 2017.

A. Mignot, C. Truillet, F. Lux, L. Sancey, C. Louis et al., A top-down synthesis route to ultrasmall multifunctional Gd-based silica nanoparticles for theranostic applications, Chemistry, vol.19, issue.19, pp.6122-6158, 2013.

J. Morlieras, S. Dufort, L. Sancey, C. Truillet, A. Mignot et al., Functionalization of small rigid platforms with cyclic RGD peptides for targeting tumors overexpressing alphavbeta3-integrins, Bioconjug Chem, vol.24, issue.9, pp.1584-97, 2013.

S. Huang, L. Wiszniewski, and S. Constant, The use of in vitro 3d cell models in drug development for respiratory diseases, pp.169-90, 2011.

W. Hoffmann, J. Gradinaru, L. Farcal, M. Caul-futy, S. Huang et al., Establishment of a human 3D tissue-based assay for upper respiratory tract absorption, Appl Vitro Toxicol, vol.4, issue.2, 2018.

L. Sancey, S. Kotb, C. Truillet, F. Appaix, A. Marais et al., Long-term in vivo clearance of gadolinium-based AGuIX nanoparticles and their biocompatibility after systemic injection, ACS Nano, vol.9, issue.3, pp.2477-88, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01207383

A. Figarol, J. Pourchez, D. Boudard, V. Forest, C. Akono et al., In vitro toxicity of carbon nanotubes, nano-graphite and carbon black, similar impacts of acid functionalization, Toxicol In Vitro, vol.30, pp.476-85, 2015.
URL : https://hal.archives-ouvertes.fr/emse-01212432

A. Kurtz-chalot, C. Villiers, J. Pourchez, D. Boudard, M. Martini et al., Impact of silica nanoparticle surface chemistry on protein corona formation and consequential interactions with biological cells, Mater Sci Eng C Mater Biol Appl, vol.75, pp.16-24, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01680498

S. Dufort, L. Sancey, and J. L. Coll, Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution, Adv Drug Deliv Rev, vol.64, issue.2, pp.179-89, 2012.

C. S. Schneider, Q. Xu, N. J. Boylan, J. Chisholm, B. C. Tang et al., Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation, Sci Adv, vol.3, issue.4, p.1601556, 2017.

B. S. Schuster, J. S. Suk, G. F. Woodworth, and J. Hanes, Nanoparticle diffusion in respiratory mucus from humans without lung disease, Biomaterials, vol.34, issue.13, pp.3439-3485, 2013.

S. K. Lai, Y. Y. Wang, and J. Hanes, Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues, Adv Drug Deliv Rev, vol.61, issue.2, pp.158-71, 2009.

S. Dufort, L. Duc, G. , S. M. Bentivegna, V. Sancey et al., The high radiosensitizing efficiency of a trace of gadolinium-based nanoparticles in tumors, Sci Rep, vol.6, p.29678, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01405772

A. Detappe, S. Kunjachan, J. Rottmann, J. Robar, P. Tsiamas et al., AGuIX nanoparticles as a promising platform for image-guided radiation therapy, Cancer Nanotechnol, vol.6, issue.1, p.4, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01275211

W. Rima, L. Sancey, M. T. Aloy, E. Armandy, G. B. Alcantara et al., Internalization pathways into cancer cells of gadolinium-based radiosensitizing nanoparticles, Biomaterials, vol.34, issue.1, pp.181-95, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00757773

K. Balogh-sivars, U. Sivars, E. Hornberg, H. Zhang, L. Branden et al., A 3D human airway model enables prediction of respiratory toxicity of inhaled drugs in vitro, Toxicol Sci, vol.162, issue.1, pp.301-309, 2018.

, Publisher's Note

, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations